title: Autoimmune diseases, their pharmacological treatment and the cardiovascular system.
abstract: Cardiovascular system involvement is a frequent complication of autoimmune diseases (AD) such as systemic lupus erythematosus, scleroderma, rheumatoid arthritis, spondyloarthropaties or psoriatic arthritis. The most common forms of such involvement are pericarditis, myocarditis, accelerated atherosclerosis resulting in myocardial infarction or stroke, arrhythmias, conduction abnormalities or congestive heart failure. Some of these manifestations may be dramatic in their course and ultimately fatal. The treatment of AD may further affect the cardiovascular system and result in a lower quality of life, higher mortality and increased cost of healthcare. The aim of this review is to discuss possible cardiac complications of various AD and the related treatment of these diseases.
authors: Marta
authors: M
authors: Jastrzębska
authors: Michael E
authors: ME
authors: Czok
authors: Department of Cardiology and Intensive Therapy, Heliodor Swiecicki University Hospital, Poznan, Poland Department of Cardiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland. pguzik@ptkardio.pl.
authors: Przemysław
authors: P
authors: Guzik
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000503:physiopathology; D015551:Autoimmunity / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000276:immunology* / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D011379:Prognosis; D012307:Risk Factors
chemical_list: D000893:Anti-Inflammatory Agents